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The Aryl Hydrocarbon Receptor Is Involved in
UVR-Induced Immunosuppression
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and Agatha Schwarz1
UVR suppresses the immune system through the induction of regulatory T cells (Tregs). UVR-induced DNA
damage has been recognized as the major molecular trigger involved, as reduction of DNA damage by enhanced
repair prevents the compromise to the immune system by UVR. Nevertheless, other signaling events may also be
involved. The aryl hydrocarbon receptor (AhR) was identified as another target for UVR, as UVR activates the AhR
and certain UVR effects were not detected in AhR-deficient cells. We studied whether the AhR is involved in
UVR-induced local immunosuppression and whether similar effects can be induced by AhR agonists. The AhR
antagonist 3-methoxy-4-nitroflavone reduced UVR-mediated immunosuppression and the induction of Tregs in
murine contact hypersensitivity (CHS). Conversely, activation of the AhR by the agonist 4-n-nonylphenol (NP)
suppressed the induction of CHS and induced antigen-specific Tregs similar to UVR. This was further confirmed
in AhR knockout mice in which UVR- and NP-induced immunosuppression were significantly reduced. Together,
this indicates that the AhR is involved in mediating UVR-induced immunosuppression. Activation of the AhR
might represent an alternative to modulate the immune system in a similar manner like UVR but without causing
the adverse effects of UVR, including DNA damage.
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INTRODUCTION
UVR, in particular the mid-wave range (UVB, 290–320 nm),
suppresses the immune system. UVR-induced immunosup-
pression exerts unique features: (1) it is caused by low
suberythemogenic doses; (2) it is antigen specific and thus
differs from immunosuppression caused by drugs; and
(3) primarily, T cell–driven reactions are affected (Schwarz,
2010). The antigen specificity is due to the generation of
regulatory T cells (Tregs). Because of their specificity, UVR-
Tregs harbor therapeutic potential. Hence, we are interested to
characterize these cells and try to elucidate the mechanisms
by which they are induced.
UVR-induced DNA damage appears to be an essential
molecular trigger for the induction of Tregs, as upon reduction
of DNA damage, Tregs are not generated (Schwarz et al.,
2005). Unless completely removed by the nucleotide excision
repair, UVR-induced DNA damage bears the risk for
malignant transformation. This is the major drawback of
utilizing UVR as a therapeutic tool. To overcome this risk,
we are searching for alternative strategies to induce Tregs,
which act in the same manner like UVR-Tregs. Recently, we
showed that injection of antimicrobial peptides may be such a
route (Navid et al., 2012).
The aryl hydrocarbon receptor (AhR) is a ubiquitously
expressed ligand-activated transcription factor involved in
the detoxification of aromatic hydrocarbons. The AhR,
however, appears to also mediate other cellular events such
as proliferation, cell growth, and differentiation (Abel and
Haarmann-Stemmann, 2010). Different low-molecular-weight
ligands bind to the AhR and act in an agonistic or antagonistic
manner, thereby modulating AhR activation. Classical ligands
of the AhR are exogenic xenobiotics such as 2,3,7,
8-tetrachlorodibenzo-p-dioxin (TCDD), benzo(a)pyrene, and
3-methylcholanthrene (Denison and Nagy, 2003). After
activation, the AhR translocates into the nucleus where it
associates with the AhR nuclear translocator. This heterodimer
then binds to xenobiotic response elements of a variety of genes
involved in the cellular detoxification pathway of xenobiotics
(Bock and Ko¨hle, 2006). One important target gene is
CYP1A1, which is widely used as a marker for AhR activation
(Fritsche et al., 2007; Hu et al., 2007; Abel and Haarmann-
Stemmann, 2010). However, the biological consequences of
AhR activation exceed detoxification processes.
The AhR was recently recognized to serve as an intra-
cellular molecular target for UVR (Fritsche et al., 2007).
ORIGINAL ARTICLE
1Department of Dermatology, University Kiel, Kiel, Germany and 2Institut fu¨r
Umweltmedizinische Forschung (IUF), Heinrich-Heine-University Du¨sseldorf,
Du¨sseldorf, Germany
Correspondence: Thomas Schwarz, Department of Dermatology, University
Kiel, Schittenhelmstrasse 7, 24105 Kiel, Germany.
E-mail: tschwarz@dermatology.uni-kiel.de
3These authors contributed equally to this work.
Received 31 January 2013; revised 5 April 2013; accepted 17 April 2013;
accepted article preview online 7 May 2013; published online 11 July 2013
Abbreviations: AhR, aryl hydrocarbon receptor; BMDC, bone marrow–derived
dendritic cell; CHS, contact hypersensitivity; DEREG, DEpletion of REGulatory
T cells; DT, diphtheria toxin; Foxp3, forkhead box P3; i.p., intraperitoneal;
KO, knockout; LC, Langerhans cell; MNF, 3-methoxy-4-nitroflavone; NP, 4-n-
nonylphenol; Oxa, oxazolone; TCDD, 2,3,7,8-tetrachlorodibenzo-p-dioxin;
Treg, regulatory T cell; UVR-Treg, UVR-induced Treg
& 2013 The Society for Investigative Dermatology www.jidonline.org 2763
UVR exposure of HaCaT cells induced translocation of the
AhR into the nucleus and, subsequently, transcription of
CYP1A1. Induction of CYP1A1 by UVR was not observed in
AhR knockout (KO) cells, indicating the crucial role of AhR in
this signaling event.
In addition, it was observed that the AhR appears to be
involved in the induction of Tregs (Quintana et al., 2008).
Owing to this fact and the observation that the AhR can be
activated by UVR, we asked whether the AhR signaling
pathway is involved in UVR-induced immunosuppression
and, if this is the case, whether similar immunosuppressive
effects can be induced by AhR ligands.
RESULTS
The AhR antagonist MNF reduces UVR-induced
immunosuppression
To clarify whether the AhR is involved in UVR-induced
immunosuppression, the murine model of contact hypersensi-
tivity (CHS) was used, in which UVR inhibits sensitization and
induces antigen-specific Tregs. To block the AhR, the specific
AhR antagonist 3-methoxy-4-nitroflavone (MNF; Lu et al.,
1995; Davis et al., 2003) was selected. Mice were exposed
to UVR on their backs for 4 consecutive days. 24 Hours after
the last exposure mice were sensitized against DNFB. One
group received MNF intraperitoneally (i.p.) 1 hour before
sensitization. After 5 days, mice were challenged, and after
further 24 hours ear swelling was measured. Sensitization and
challenge with DNFB induced pronounced ear swelling in
positive control mice (Figure 1a; #1). The CHS reaction was
significantly reduced on UVR exposure (Figure 1a; #3). In
contrast, injection of MNF significantly reduced UVR-induced
immunosuppression (Figure 1a; #4). MNF alone had no effect
on CHS (Figure 1a; #5).
To study whether MNF prevents the induction of Tregs by
UVR, adoptive transfer experiments were conducted. Lymph
node cells and splenocytes were isolated from mice that were
UVR exposed (Figure 1a; #3), or in addition treated with MNF
(Figure 1a; #4) and injected into naive mice. After 24 hours,
recipients were sensitized and 5 days later challenged with
DNFB. The ear swelling response in recipients injected with
cells isolated from only UV-irradiated donors was significantly
reduced, suggesting that cells with regulatory properties had
developed in the donors (Figure 1b; #3). In contrast, CHS was
not suppressed in animals injected with cells obtained from
UVR-exposed and MNF-treated mice, indicating that antag-
onizing the AhR prevents UVR-mediated induction of Tregs
(Figure 1b; #4).
Inhibition of the AhR downregulates the suppressive activity of
UVR-Tregs
The adoptive transfer experiments implied that blocking of the
AhR inhibits the development of UVR-Tregs. However, one
cannot exclude that MNF blocks their suppressive activity. To
clarify the latter issue, splenocytes and lymph node cells were
obtained from mice that were sensitized through UVR-
exposed skin. Cells were separated into CD4þCD25 and
CD4þCD25þ T cells through magnetobead separation. The
latter fraction that contains UVR-Tregs was incubated in vitro
with MNF. After 24 hours, cells were harvested, washed, and
injected intravenously into naive mice that were DNFB
sensitized 24 hours later. The ear swelling response revealed
that, in contrast to untreated UVR-Tregs (Figure 2a; #3), UVR-
Tregs incubated with MNF were less effective in inhibiting
CHS in the recipients (Figure 2a; #4). In addition, the
incubation of CD4þCD25þ cells with MNF caused a reduc-
tion in the expression of Foxp3 (forkhead box P3; Figure 2b).
These data indicate that antagonizing the AhR reduces the
expression of Foxp3, which appears to be associated with a
mitigation of the suppressive activity of UVR-Tregs.
The AhR agonist NP induces immunosuppression
The data obtained so far suggest that the AhR is involved in
mediating UVR-induced immunosuppression. We next
checked whether mere activation of the AhR can exert
similar immunosuppressive features as UVR. To activate the
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Figure 1. The 3-methoxy-4-nitroflavone (MNF) reduces UVR-induced
immunosuppression. (a) Mice were irradiated with UVR on 4 consecutive days
(#3). At 24 hours after the last irradiation, mice were sensitized with DNFB
through UVR-exposed skin. After 5 days, ears were challenged with DNFB,
and ear swelling was measured 24 hours later. One group of UVR-exposed
mice received MNF (20mM, 200ml) intraperitoneally (i.p.; #4) 1 hour
before every UVR exposure. As a control, unirradiated mice were injected
with MNF alone (#5). Positive control (Pos Co) mice were sensitized and
challenged, and negative control (Neg Co) mice were only challenged. Bars
show mean±SD of increase in ear thickness expressed as the difference
between the thicknesses of the challenged ear compared with the vehicle-
treated ear. *Po0.05 versus Pos Co; **Po0.05 versus UVR. (b) Lymph node
cells and splenocytes were obtained from the UVR and UVRþMNF groups
(a, #3 and #4), respectively, and injected intravenously (i.v.) into naive mice
(Transfer) 24 hours before sensitization. After 5 days, ears were challenged and
ear swelling measured after 24 hours. *Po0.005 versus Pos Co; **Po0.005
versus UVR.
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AhR, we utilized the AhR agonist 4-n-nonylphenol (NP;
Bonefeld-Jrgensen et al., 2007). The i.p.-injected NP
induced the expression of the AhR-controlled enzyme
CYP1A1 in lymph nodes as demonstrated by quantitative
real-time PCR (data not shown), indicating that the dose
injected activates the AhR. Mice were injected i.p. with NP
on 4 days before sensitization. As observed for UVR, CHS was
significantly suppressed by NP (Figure 3a; #3).
To analyze whether NP induces antigen-specific Tregs,
lymph node cells and splenocytes obtained from DNFB-
sensitized and NP-treated mice were injected into naive
animals. After 24 hours, one group of recipients was sensitized
with DNFB, and the other group with the unrelated hapten
oxazolone (Oxa). Recipients sensitized with DNFB (Figure 3b;
#3) were significantly suppressed in their ear swelling
response, whereas recipients sensitized with Oxa revealed a
pronounced CHS reaction (Figure 3b; #6). This indicates that
NP induces Tregs that act in an antigen-specific manner.
NP-induced Tregs belong to the CD4þCD25þ subtype and
express Foxp3
To analyze whether NP-induced Tregs belong to the CD4þ
CD25þ subset, mice were injected i.p. with NP before
sensitization. After 5 days, lymph node cells and splenocytes
were obtained from the NP-treated mice and separated into
CD4þCD25þ and CD4þCD25 T cells. Both fractions were
injected intravenously into naive recipients 24 hours before
sensitization with DNFB. Mice injected with CD4þCD25
cells (Figure 4a; #3) reacted with a pronounced ear swelling
response similar to the positive control (Figure 4a; #1). CHS
was significantly reduced in recipients receiving CD4þ
CD25þ cells (Figure 4a; #4), indicating that NP induces
CD4þCD25þ Tregs.
Foxp3 is a key transcription factor in the development of
natural CD4þCD25þ Tregs (Fontenot et al., 2003; Hori et al.,
2003) and expressed by UVR-Tregs (Schwarz et al., 2011). To
clarify whether the same applies for NP-induced Tregs, we
utilized DEREG (DEpletion of REGulatory T cells) mice that
express a diphtheria toxin (DT) receptor–enhanced green
fluorescent protein under control of the foxp3 gene locus
(Lahl et al., 2007). Thus, injection of DT results in the selective
depletion of Foxp3-positive cells. DEREG mice were injected
i.p. with NP on 4 days. After 24 hours, the last treatment
animals were DNFB sensitized. After 48 hours, DT was
injected for 3 days. At 5 days after sensitization, lymph node
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Figure 2. The 3-methoxy-4-nitroflavone (MNF) downregulates the
suppressive activity and the expression of forkhead box P3 (Foxp3) by UVR-
regulatory T cells (Tregs). (a) Mice were sensitized with DNFB through UVR-
exposed skin. After 5 days, lymph node cells and splenocytes were obtained
and separated into CD4þCD25þ Tregs and CD4þCD25 T cells. Tregs were
incubated with 20mM MNF (#4) or left unstimulated (#3). After 24 hours, cells
were washed and injected intravenously (i.v.; 5 105) into naive mice that
were sensitized and challenged with DNFB. *Po0.00005 versus Pos Co;
**Po0.005 versus Tregs. Neg Co, negative control; Pos Co, positive control.
(b) Lymph node cells and splenocytes were obtained from UVR and DNFB-
treated mice and separated into CD4þCD25 T cells, CD4þCD25þ (Tregs),
and Tregs incubated with MNF. Cells were stained with an antibody directed
against Foxp3 and subjected to FACS analysis. Histograms show cell number (y
axis) versus fluorescence intensity (x axis).
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Figure 3. The aryl hydrocarbon receptor (AhR) agonist 4-n-nonylphenol (NP)
induces immunosuppression. (a) Mice were injected intraperitoneally (i.p.)
with 600 nM NP (200ml) for 4 consecutive days (#3). After 24 hours, mice were
sensitized with DNFB. After 5 days, ears were challenged with DNFB and ear
swelling was measured 24 hours later. *Po0.0005 versus Pos Co. Neg Co,
negative control; Pos Co, positive control. (b) Lymph node cells and
splenocytes were obtained from NP-injected mice (a, #3) and transferred
intravenously (i.v.; 5 107 per mouse) into naive mice (Transfer) 24 hours
before sensitization with DNFB or the irrelevant hapten oxazolone (Oxa). After
5 days, ears were challenged with the respective hapten and ear swelling was
measured after 24 hours. *Po0.05 versus Pos Co; NS, not significant.
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cells and splenocytes were obtained and injected into naive
wild-type mice. After 24 hours, the recipients were sensitized
against DNFB and ear challenge was carried out 5 days
thereafter. Cells obtained from DEREG mice treated with NP
suppressed CHS in the recipients (Figure 4b; #3). In contrast,
sensitization was not reduced upon transfer of cells obtained
from DEREG mice treated with NP and DT (Figure 4b; #4),
indicating that NP-induced Tregs express Foxp3.
AhR-KO mice are resistant to NP- and UVR-induced
immunosuppression
To exclude that NP inhibits sensitization and induces Tregs
through other mechanisms not involving the AhR, AhR-KO
mice were injected with NP on 4 days before sensitization.
After 5 days, ear challenge was carried out. NP significantly
suppressed sensitization in wild-type but not in AhR-KO mice
(Figure 5a; #4). Similarly, transfer of lymph node cells from
AhR-KO mice into naive animals did not suppress sensitiza-
tion of the recipients (Figure 5b; #4). This indicates that
prevention of sensitization and induction of Tregs by NP
involves the AhR.
We utilized the AhR-KO mice to further confirm the
involvement of the AhR in UVR-induced immunosuppression.
DNFB was painted on UVR-exposed skin of AhR-KO mice. In
contrast to wild-type mice, AhR-KO mice turned out to be
fully sensitized, despite the application of the hapten onto
UVR-irradiated skin (Figure 5a; #3). Finally, splenocytes and
lymph nodes cells were obtained from the UVR-exposed AhR-
KO mice and injected intravenously into naive mice. After
sensitization, the recipients responded to the challenge with a
CHS response comparable to positive controls (Figure 5b; #3),
indicating that UVR-Tregs had not developed in AhR-KO
mice.
Injection of NP-treated dendritic cells induces Tregs
As the AhR appears to be involved in UVR-induced immuno-
suppression, the question arises as to which cell type
needs to be activated by UVR through the AhR to initiate
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Figure 4. The 4-n-nonylphenol (NP) induces CD4þCD25þ regulatory T cells
(Tregs) expressing forkhead box P3 (Foxp3). (a) Mice were injected
intraperitoneally (i.p.) with NP for 4 days and sensitized with DNFB. After
5 days, lymph node cells and splenocytes were obtained and separated
into CD4þCD25þ and CD4þCD25 T cells. CD4þCD25 (#3) and
CD4þCD25þ (#4) were injected intravenously (i.v.; 5 105 per mouse) into
naive mice 24 hours before sensitization with DNFB. Ears were challenged and
swelling measured. *Po0.05 versus Pos Co; **Po0.005 versus CD4þCD25 .
Neg Co, negative control; Pos Co, positive control. (b) DEREG (DEpletion of
REGulatory T cells) mice were injected intraperitoneally (i.p.) with NP for
4 days. After 24 hours, mice were sensitized with DNFB. After 48 hours, one
group (#4) received 1mg diphtheria toxin (DT) on 3 days. At 5 days after
sensitization, splenocytes and lymph node cells were obtained and injected i.v.
into naive wild-type (WT) animals. Recipients were sensitized against DNFB
24 hours after injection, and were challenged 5 days later. *Po0.0005 versus
Pos Co; **Po0.000005 versus DT.
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Figure 5. UVR and 4-n-nonylphenol (NP) do not induce immunosuppression
in aryl hydrocarbon receptor knockout (AhR-KO) mice. (a) AhR-KO mice
were UV irradiated (#3) or injected intraperitoneally (i.p.) with NP (#4) for
4 days. After 24 hours, mice were sensitized with DNFB. After 5 days, ears
were challenged with DNFB and ear swelling was measured 24 hours later.
Neg Co, negative control; Pos Co, positive control. (b) Lymph node cells and
splenocytes were obtained from the UV-irradiated or NP-treated groups (a, #3
and #4) and injected intravenously (i.v.; 5 107 per mouse) into naive C57BL/
6 mice (Transfer) 24 hours before sensitization with DNFB. After 5 days, ears
were challenged with DNFB and ear swelling was measured after further
24 hours. NS, not significant.
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immunosuppression. As UVB does not penetrate beyond the
upper dermis, most likely the candidates are located in the
epidermis. As the AhR is ubiquitously expressed, exact
identification will only be possible by transgenic mice in
which the AhR is selectively knocked out in keratinocytes,
Langerhans cells (LCs), or dermal dendritic cells. For UVR-
induced immunosuppression, LCs appear to be required as
depletion of LCs in Langerin DT knock-in mice was associated
with a loss of UVR-induced immunosuppression (Schwarz
et al., 2010). Hence, we surmised that, rather than
keratinocytes, dendritic cells are crucially involved in AhR-
mediated immunosuppression. To further elucidate this
phenomenon, we asked whether activation of the AhR in
antigen-presenting cells induces immunosuppression. Thus,
dendritic cells were obtained from the bone marrow (BMDCs),
cultured in the absence or presence of NP, coupled with
DNBS and injected subcutaneously into naive mice.
Challenge with DNFB was carried out 5 days later. Mice
injected with DNBS-coupled BMDCs responded with
pronounced ear swelling (Figure 6a; #1). In contrast, upon
injection of DNBS-coupled BMDCs, which were cultured with
NP (#2), the recipients revealed a reduced ear swelling
response. To analyze whether NP-treated BMDCs induce
Tregs, lymph node cells and splenocytes obtained from donors
(Figure 6a; #1 and #2) were injected into naive animals
(Figure 6, Transfer) that were sensitized 24 hours later. Reci-
pients of cells obtained from mice injected with NP-treated
BMDCs were significantly suppressed in their ear swelling
response (Figure 6b; #4), whereas recipients of cells from
donors injected with the untreated BMDCs revealed a pro-
nounced CHS reaction (Figure 6b; #3). These results imply that
dendritic cells are essentially involved in AhR-mediated
immunosuppression.
DISCUSSION
The major conclusions of this paper are 2-fold: first, the AhR is
involved in UVR-induced immunosuppression; second, acti-
vation of the AhR induces similar immunosuppressive effects
as observed with UVR.
The molecular mechanisms involved in UVR-induced
immunosuppression appear to be complex. For a long time,
it was assumed that UVR-induced DNA damage is the major,
even the only molecular, event involved. This was based on
the findings that reduction of DNA damage was associated
with a mitigation of UVR-induced immunosuppression
(Applegate et al., 1989; Kripke et al., 1992). This was
confirmed by studies demonstrating that injection of
mediators, which induce DNA repair such as IL-12, IL-18,
IL-23 (Schwarz and Schwarz, 2009), and vitamin D (Halliday,
2010), reduced UVR-induced immunosuppression. As mostly
reduction but not total prevention was observed, it was
assumed that additional signaling pathways may be involved.
Cis–urocanic acid has been recognized rather early as an
essential component involved in UVR-induced immunosup-
pression, as removal of cis–urocanic acid by tape stripping
reduced immunosuppression (De Fabo and Noonan, 1983).
Similar findings were obtained by the injection of anti-cis–
urocanic acid antibodies (Beissert et al., 2001).
On the basis of our data, the AhR can be added to the list of
molecular targets that the UVR utilizes for exerting immuno-
suppression. This is indicated by the findings that AhR
antagonists reduce UVR-induced immunosuppression and that
AhR-KO mice are reduced in their immunosuppressive
response to UVR. Initially, we used the AhR antagonist
resveratrol that mitigated UVR-induced suppression. As resver-
atrol exerts additional activities including antioxidative effects
(Afaq and Katiyar, 2011), we utilized the more specific AhR
antagonist MNF (Lu et al., 1995; Davis et al., 2003).
Prevention of UVR-induced immunosuppression by MNF
and the fact that AhR-KO mice turned out to be resistant to
UVR-induced immunosuppression indicates that the AhR is
involved in the compromise of UVR to the immune system.
This is not surprising as it has been recognized that the
function of the AhR goes beyond its detoxifying effects.
Activation of the AhR induces transcription of various genes
involved in the regulation of cell differentiation, proliferation,
and activation (Schmidt and Bradfield, 1996). There is also
evidence that activation of the AhR can modulate immune
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Figure 6. Injection of 4-n-nonylphenol (NP)-treated bone marrow–derived
dendritic cells (BMDCs) induces regulatory T cells (Tregs). (a) BMDCs were
incubated with (#2) or without NP (#1). After 8 days, mature BMDCs were
harvested, pulsed with DNBS (1 mM for 30 minutes), washed, and injected
subcutaneously (s.c.; 7 105) into naive mice. After 5 days, ear challenge
against DNFB was carried out and ear swelling was measured. *Po0.002
versus BMDCs. Neg Co, negative control; Pos Co, positive control. (b) Lymph
node cells and splenocytes were obtained from mice that had received
untreated or NP-treated BMDCs (a, #1 and #2) and injected intravenously (i.v.;
5 107) into naive mice (Transfer, #3 and #4) 24 hours before sensitization.
After 5 days, challenge was carried out and ear swelling was measured.
*Po0.002 versus Pos Co; **Po0.005 versus BMDCs.
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responses (Kerkvliet, 2009). This was first indicated by the
observation that benzo[a]pyrene induces hyporesponsiveness
against DNFB (Ruby et al., 1989). The AhR ligand TCDD was
shown to induce Tregs (Funatake et al., 2005; Marshall et al.,
2008; Quintana et al., 2008). In turn, activation of the AhR by
6-formylindolo[3,2-b]carbazole inhibited development of
Tregs and stimulated the differentiation of T helper type 17
cells (Quintana et al., 2008). This indicated that AhR regulates
both Tregs and T helper type 17 cell differentiation in a ligand-
specific manner. The underlying mechanisms explaining these
diverse effects still remain to be determined. The involvement
of the AhR in T-cell development was further confirmed by the
observation that activation of the AhR in the presence of
transforming growth factor-b1 induced Foxp3þ human Tregs
(Gandhi et al., 2010).
The AhR appears to influence maturation of LCs, as AhR-
deficient LCs were smaller and less granular and did not
upregulate costimulatory molecules (Jux et al., 2009). Their
phagocytic capacity was higher, another indicator of lower
maturation. CHS to FITC was reduced in AhR-deficient mice.
This is in contrast to our findings. Whether this is because of
different types of haptens or concentrations applied remains to
be determined. The impaired response in the presence of
immature LCs appears to be surprising, as several studies have
shown that LCs are not required for the induction of CHS
(Romani et al., 2010), but rather involved in downregulating
immune responses including UVR-induced suppression of the
induction of CHS (Schwarz et al., 2010). In addition,
immunosuppression does not appear to be the only UVR
effect in which the AhR is involved, as UVR-mediated tanning
was reduced in AhR-KO mice (Jux et al., 2011).
As AhR is involved in UVR-induced immunosuppression,
we studied whether similar immunosuppressive effects can be
induced by AhR ligands. Because of its high toxicity, we
avoided TCDD, which was shown to induce Tregs (Funatake
et al., 2005; Marshall et al., 2008; Quintana et al., 2008). NP
is an alkylphenol interacting with the AhR (Kru¨ger et al.,
2008). Its in vivo activity was proven by quantitative real-time
PCR demonstrating the upregulation of CYP1A1 upon
injection of NP. This was absent in AhR-KO mice (data not
shown). Injection of NP inhibited the induction of CHS and
induced Tregs. NP-induced Tregs act in an antigen-specific
manner, as transfer of Tregs obtained from NP- and
DNFB-treated donors inhibited the induction of CHS against
DNFB but not against Oxa. Depletion studies revealed that
NP-induced Tregs, such as UVR-Tregs, belong to the
CD4þCD25þ subtype and express Foxp3 as demonstrated
in DEREG mice. NP can interact with the estrogen receptor
(Goksyr, 2006; Kru¨ger et al., 2008). However, the effects of
NP on CHS are not mediated through this pathway, as NP did
not exert any immunosuppressive features in AhR-KO mice.
We surmised that activation of the AhR in dendritic cells is
an essential event in AhR ligand-induced immunosuppression.
This is based on the observation that injection of NP-treated
and DNBS-coupled BMDCs rendered recipient mice
unresponsive to DNFB. As LCs are crucially required for
mediating UVR-induced local immunosuppression (Schwarz
et al., 2010), we speculate that cutaneous dendritic cells, most
likely LCs, are those cells that, on activation of the AhR by
UVR, mediate the inhibition of CHS and the induction of
Tregs. However, we cannot definitely rule out that activation
of the AhR in keratinocytes is involved as well. This issue
could be ultimately clarified only by generating transgenic
mice in which the AhR is selectively knocked out either in
keratinocytes or dendritic cells.
In addition, we observed that Tregs require AhR to exert
their suppressive features. The loss of suppressive activity
caused by MNF was not due to the induction of cell death
(data not shown), but associated with a downregulation of
Foxp3. On the other hand, in vitro incubation of CD4þCD25-
T cells with NP did not shift them into a regulatory phenotype
(data not shown). However, the limitation of this experiment is
the fact that we may have not yet found the optimal conditions
concerning concentrations or kinetics.
Taken together, our data suggest that AhR is involved in the
induction of Tregs and in the maintenance of their suppressive
activity. The first activity appears to be dependent on the
activation of the AhR in dendritic cells, the latter in the Tregs
themselves. By which ligands the latter effect is driven remains
to be determined. Thus, our data identify the AhR as an
additional molecular target involved in UVR-induced immu-
nosuppression. Hence, the AhR appears as a potential target to
induce antigen-specific immunosuppression. Activation of the
AhR might represent an alternative to modulate the immune
system in a similar manner like UVR, but without causing the
adverse effects of UVR including DNA damage.
MATERIALS AND METHODS
Animals
Female, 7- to 8-week-old C57BL/6 mice were purchased from Charles
River Laboratories (Sulzfeld, Germany). AhR-KO mice (C57BL/6
were provided by J Krutmann (Schmidt et al., 1996). DEREG mice
were provided by T Sparwasser (Lahl et al., 2007). To deplete Foxp3-
positive cells, mice were injected i.p. with 1mg DT (Merck, Darmstadt,
Germany). Mice were bred in the central animal facilities of the
University Clinics Schleswig-Holstein. Animal care was utilized
by expert personnel under specific pathogen-free conditions, in
compliance with relevant laws and institutional guidelines.
Reagents
As an AhR agonist, NP (Sigma-Aldrich, Taufkirchen, Germany)
was used, and as an antagonist MNF (ICC Chemical Corporation,
New York, NY) was used.
UVR-induced immunosuppression
Mice were irradiated with 1.5 kJ m 2 UVR on their shaved backs for
4 consecutive days using fluorescent bulbs (TL12, Philips, Eindhoven,
The Netherlands) that emit most of their energy within the UVB
range. After 24 hours, the last exposure animals were sensitized by
painting 50ml of DNFB solution (0.5% in acetone/olive oil, 4:1) on
the shaved back. After 5 days, ear challenge was carried out with
20ml of 0.3% DNFB on the left ear and the ear swelling response was
measured with a spring-loaded micrometer 24 hours later. For
sensitization against Oxa, 100ml of a 2% solution and for challenge
20ml of a 1% solution were used. Positive control mice were
sensitized and challenged, whereas negative control mice were only
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challenged. The ear swelling response was determined as the
difference in ear thickness of the hapten-treated ear compared with
vehicle-treated ear and expressed in cm 3 (mean±SD).
NP-induced immunosuppression
Mice were injected on 4 consecutive days with 200ml 600 nM NP.
After 24 hours, mice were sensitized, and 5 days later they were
challenged.
Generation of Tregs
Mice were exposed to UVR or treated with NP. At 24 hours after the
last treatment, animals were sensitized. After 5 days, lymph nodes
and spleens were collected and single-cell suspensions were pre-
pared. CD4þCD25þ and CD4þCD25 T cells were isolated
through magnet-activated cell sorter (MACS, Miltenyi Biotec, Ber-
gisch Gladbach, Germany) using the CD4þCD25þ Regulatory T-cell
Isolation Kit (Miltenyi Biotec). For adoptive transfer, lymph nodes
cells and splenocytes obtained from donor animals (5 107) were
injected intravenously into naive recipients. For adoptive transfer of
CD4þCD25þ and CD4þCD25 T cells, 5 105 cells were used.
Recipients were sensitized 24 hours after injection and ear challenged
5 days later.
Generation of dendritic cells
BMDCs were generated by culture of bone marrow cells obtained
from tibias (Schwarz and Schwarz, 2010). The expression of surface
molecules characteristic for adult BMDC (major histocompatibility
complex class II) was determined in representative samples by flow
cytometry.
Statistical analysis
Statistical analysis was performed using Student’s t-test. Differences
between the means±SD and the corresponding control value with
Po0.05 were considered statistically significant. Unless otherwise
stated, data show one representative of three independently con-
ducted experiments with at least six mice per group.
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